Galashiels, Scotland, 1 April 2009: ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, is pleased to announce the appointment, with immediate effect, of Numis Securities Limited as Joint Corporate Broker. Numis will work alongside Morgan Stanley Securities Limited, who remain as joint broker.
Additionally, ProStrakan announces that it plans to issue its Interim Management Statement on Thursday, 14 May 2009.
